Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Hematologic Neoplasms 3Pseudomonas Infections 1Pneumonia 1Neutropenia 1Neoplasms 1Gram-Negative Bacterial Infections 1Febrile Neutropenia 1Bacteremia 1

Interventions

pegfilgrastim 30Filgrastim 29Cyclophosphamide 10pegylated granulocyte colony-stimulating factor 8Docetaxel 8Etoposide 7Cytarabine 7Ciprofloxacin 6Cefepime 6Vancomycin 5Leucovorin 5Fluorouracil 5eflapegrastim 4Granulocyte Colony-Stimulating Factor 4Doxorubicin 4Peripheral Blood Stem Cell Transplantation 3Mitoxantrone 3Methotrexate 3Levofloxacin 3Irinotecan 3Idarubicin 3Daunorubicin 3Cyclosporine 3Caspofungin 3Carboplatin 3Amikacin 3trifluridine tipiracil drug combination 2plerixafor 2liposomal amphotericin B 2Vincristine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neutropenia × ceftolozane, tazobactam drug combination × Clear all
NCT06422533 2024-06-04

Ceftolozane/Tazobactam vs. Piperacillin/Tazobactam for the Treatment of Bacteremia in Hemato-oncological Patients

Instituto Nacional de Cancerologia de Mexico

Phase NA Recruiting
226 enrolled
Other hematologic neoplasm

Neutropenia, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡